Characterisation of Recombinant Human Erythropoietin Obtained from CHOpE—Erythropoietin Producing Strain of Chinese Hamster Ovary Cells

Development and implementation in clinical practice of recombinant human erythropoietins (rhEPOs) remain a priority task today. Additional studies were performed in order to obtain clinical trial authorisation for rhEPO tablets for oral use. The studies were aimed to demonstrate the suitability of t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: I. F. Radaeva, V. A. Ternovoy, A. O. Sementsova, N. B. Dumchenko, E. A. Nechaeva
Format: Artigo
Jezik:Russo
Izdano: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2020-06-01
Serija:Биопрепараты: Профилактика, диагностика, лечение
Teme:
erythropoietin producer
chope cell strain
nucleotide sequence
molecular weight
identification
peptide mapping
dimers
sialic acids
Online pristup:https://www.biopreparations.ru/jour/article/view/272
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items